| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773803 | Kidney International Reports | 2018 | 13 Pages |
Abstract
Our data indicate that circulating MASP-3 levels could be used as a biomarker of disease severity in IgAN and that glomerular staining for FHR5 could both indicate alternative complement pathway activation and be a tissue marker of disease severity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Nicholas R. Medjeral-Thomas, Anne Troldborg, Nicholas Constantinou, Hannah J. Lomax-Browne, Annette G. Hansen, Michelle Willicombe, Charles D. Pusey, H. Terence Cook, Steffen Thiel, Matthew C. Pickering,